2023-2029 Global Gene Therapy in CNS Disorder Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Gene Therapy in CNS Disorder Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Gene Therapy in CNS Disorder Market Restraints
Table 3. Gene Therapy in CNS Disorder Market Trends
Table 4. Gene Therapy in CNS Disorder Industry Policy
Table 5. Global Gene Therapy in CNS Disorder Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Gene Therapy in CNS Disorder Revenue Market Share by Company (2018-2023)
Table 7. Global Gene Therapy in CNS Disorder Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Gene Therapy in CNS Disorder Mergers & Acquisitions, Expansion Plans
Table 9. Global Gene Therapy in CNS Disorder Manufacturers Product Type
Table 10. China Gene Therapy in CNS Disorder Revenue by Company (2018-2023) & (US$ million)
Table 11. China Gene Therapy in CNS Disorder Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Gene Therapy in CNS Disorder Upstream (Raw Materials)
Table 13. Global Gene Therapy in CNS Disorder Typical Customers
Table 14. Gene Therapy in CNS Disorder Typical Distributors
Table 15. By Type, Global Gene Therapy in CNS Disorder Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Gene Therapy in CNS Disorder Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Gene Therapy in CNS Disorder Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Gene Therapy in CNS Disorder Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029
Table 22. Voyager Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 23. Voyager Therapeutics Company Profile and Main Business
Table 24. Voyager Therapeutics Gene Therapy in CNS Disorder Models, Specifications and Application
Table 25. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
Table 26. Voyager Therapeutics Recent Developments
Table 27. Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 28. Spark Therapeutics Company Profile and Main Business
Table 29. Spark Therapeutics Gene Therapy in CNS Disorder Models, Specifications and Application
Table 30. Spark Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
Table 31. Spark Therapeutics Recent Developments
Table 32. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 33. Novartis AG Company Profile and Main Business
Table 34. Novartis AG Gene Therapy in CNS Disorder Models, Specifications and Application
Table 35. Novartis AG Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
Table 36. Novartis AG Recent Developments
Table 37. Bluebird Bio Inc. Company Information, Head Office, Market Area and Industry Position
Table 38. Bluebird Bio Inc. Company Profile and Main Business
Table 39. Bluebird Bio Inc. Gene Therapy in CNS Disorder Models, Specifications and Application
Table 40. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
Table 41. Bluebird Bio Inc. Recent Developments
Table 42. Biogen Company Information, Head Office, Market Area and Industry Position
Table 43. Biogen Company Profile and Main Business
Table 44. Biogen Gene Therapy in CNS Disorder Models, Specifications and Application
Table 45. Biogen Gene Therapy in CNS Disorder Revenue and Gross Margin, 2018-2023
Table 46. Biogen Recent Developments
List of Figure
Figure 1. Gene Therapy in CNS Disorder Picture
Figure 2. Global Gene Therapy in CNS Disorder Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Gene Therapy in CNS Disorder Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Gene Therapy in CNS Disorder Market Share of Global
Figure 5. Global Gene Therapy in CNS Disorder Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Gene Therapy in CNS Disorder Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Gene Therapy in CNS Disorder Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Gene Therapy in CNS Disorder Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Gene Therapy in CNS Disorder Industry Chain
Figure 10. Viral Gene Therapy
Figure 11. Non-viral Gene Therapy
Figure 12. By Type, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029
Figure 14. Alzheimer's Disease
Figure 15. Huntington's Disease
Figure 16. Parkinson's Disease
Figure 17. Batten Disease
Figure 18. By Application, Global Gene Therapy in CNS Disorder Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029
Figure 20. By Region, Global Gene Therapy in CNS Disorder Revenue Market Share, 2018-2029
Figure 21. North America Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023
Figure 23. Europe Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023
Figure 27. South America Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Gene Therapy in CNS Disorder Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Gene Therapy in CNS Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 32. By Type, U.S. Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 34. Europe Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 36. By Type, Europe Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 38. China Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 40. By Type, China Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 42. Japan Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 44. By Type, Japan Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 48. By Type, South Korea Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 54. India Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 56. By Type, India Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Gene Therapy in CNS Disorder Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Gene Therapy in CNS Disorder Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Gene Therapy in CNS Disorder Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets